Pelvic Pain and Urinary Urgency Frequency (PUF) Patient Symptom Scale
The Pelvic Pain and Urgency/Frequency (PUF) patient symptom scale is a diagnostic tool used to screen patients with chronic pelvic pain. Developed by C. Lowell Parsons, MD, the PUF self-report questionnaire uses a symptom score (which measures how often a patient experiences problems) as well as a bother score (which notes the degree to which the symptoms bother the patient); the bother and symptom score combine for a total PUF score. The scale takes about 5 minutes to complete. Scores range between 0 and 35, and studies have indicated that a score greater than 12 is indicative of significant symptoms.
The Pelvic Pain and Urgency/Frequency (PUF) patient symptom scale is a diagnostic tool used to screen patients with chronic pelvic pain. Developed by C. Lowell Parsons, MD, the PUF self-report questionnaire uses a symptom score (which measures how often a patient experiences problems) as well as a bother score (which notes the degree to which the symptoms bother the patient); the bother and symptom score combine for a total PUF score. The scale takes about 5 minutes to complete. Scores range between 0 and 35, and studies have indicated that a score greater than 12 is indicative of significant symptoms.
Download the Pelvic Pain and Urgency/Frequency (PUF) Patient Symptom Scale (PDF)
More About Pelvic Pain and Urgency/Frequency
Newsletter
Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.
Study finds pregnancy risks higher with ART in kidney transplant recipients
July 11th 2025Women with kidney transplants who conceive through assisted reproductive technology face increased risks of complications such as hypertension, preterm birth, and cesarean delivery, according to new research.
Read More
Trimethoprim–sulfamethoxazole not found to increase infant birth weight in HIV cases
July 9th 2025A recent randomized trial found no significant improvement in birth weight or key birth outcomes from antenatal trimethoprim–sulfamethoxazole prophylaxis in human immunodeficiency virus-positive pregnant women.
Read More
